Publications by authors named "Marco Berruti"

Claim this Profile
G
General Practitioners as partners for a shared management of chronic HIV infection: An insight into the perspectives of Italian People Living with HIV.
Serena Rita Bruno, Mariacristina Poliseno, Francesca Vichi, Sara Esperti, Antonio Di Biagio, Marco Berruti

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia.
Alessandro Cozzi-Lepri, Vanni Borghi, Salvatore Rotundo, Bianca Mariani, Anna Ferrari, Marco Berruti

Front Med (Lausanne)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study.
Matteo Bassetti, Antonio Vena, Daniele R Giacobbe, Cecilia Trucchi, Filippo Ansaldi, Marco Berruti

Infect Dis Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort.
Andrea De Vito, Annarita Botta, Marco Berruti, Valeria Castelli, Vincenzo Lai

J Pers Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region.
Antonio Vena, Giovanni Cenderello, Elisa Balletto, Laura Mezzogori, Alessandro Santagostino Barbone, Marco Berruti

J Clin Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria.
Alessandro Russo, Marco Berruti, Daniele Roberto Giacobbe, Antonio Vena, Matteo Bassetti

Expert Rev Anti Infect Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating fostemsavir as a therapeutic option for patients with HIV.
Marco Berruti, Rachele Pincino, Lucia Taramasso, Antonio Di Biagio

Expert Opin Pharmacother· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study.
Daniele Roberto Giacobbe, Chiara Russo, Veronica Martini, Silvia Dettori, Federica Briano, Marco Berruti

Antibiotics (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-Fluorodeoxyglucose positron emission tomography/computed tomography as a diagnostic and follow-up tool in endocarditis of prosthetic valve and aortic valved tube: a case report.
Elisa Ricciardi, Alessandro Moscatelli, Marco Berruti, Maria Isabella Donegani, Malgorzata Karolina Mikulska

Eur Heart J Case Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study.
Antonio Vena, Lucia Taramasso, Antonio Di Biagio, Malgorzata Mikulska, Chiara Dentone, Marco Berruti

Infect Dis Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injectable Antiretroviral Drugs: Back to the Future.
Marco Berruti, Niccolò Riccardi, Diana Canetti, Sergio Lo Caputo, Lucia Taramasso

Viruses· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy.
Massimiliano Fabbiani, Alberto Borghetti, Nicola Squillace, Manuela Colafigli, Lucia Taramasso, Marco Berruti

J Acquir Immune Defic Syndr· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
Filippo Del Puente, Marco Berruti, Niccolò Riccardi, Antonio Di Biagio

J Antimicrob Chemother· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy.
Antonio Vena, Daniele Roberto Giacobbe, Antonio Di Biagio, Malgorzata Mikulska, Lucia Taramasso, Marco Berruti

Clin Microbiol Infect· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection.
Lucia Taramasso, Antonio Di Biagio, Malgorzata Mikulska, Daniele Roberto Giacobbe, Antonio Vena, Marco Berruti

Eur J Clin Invest· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adequate duration of therapy in severe fungal infections.
Matteo Bassetti, Daniele R Giacobbe, Marco Berruti, Filippo Del Puente, Antonio Vena

Curr Opin Crit Care· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
Malgorzata Mikulska, Laura Ambra Nicolini, Alessio Signori, Antonio Di Biagio, Chiara Sepulcri, Marco Berruti

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Negative Serum (1,3)-β-D-glucan in Patients With Candidemia.
Daniele Roberto Giacobbe, Marco Berruti, Malgorzata Mikulska

Clin Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors.
Antonio Vena, Marco Berruti, Andrea Adessi, Pietro Blumetti, Michele Brignole

J Clin Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The switch from tenofovir disoproxil fumarate to tenofovir alafenamide determines weight gain in patients on rilpivirine-based regimen.
Lucia Taramasso, Marco Berruti, Federica Briano, Antonio Di Biagio

AIDS· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of fosfomycin for multidrug-resistant gram-negative infections.
Matteo Bassetti, Elena Graziano, Marco Berruti, Daniele Roberto Giacobbe

Curr Opin Infect Dis· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibalizumab and Fostemsavir in the Management of Heavily Pre-Treated HIV-infected Patients.
Niccolò Riccardi, Marco Berruti, Filippo Del Puente, Lucia Taramasso, Antonio Di Biagio

Recent Pat Antiinfect Drug Discov· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis